Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
ACS Omega|April 22, 2022
Metabolic, Pharmacokinetic, and Activity Profile of the Liver Stage Antimalarial (RC-12)Yuxiang Dong, Yogesh Sonawane, Steven P Maher, et al.Future Medicinal Chemistry|October 23, 2013
Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruziMartine Keenan, Paul W Alexander, Jason H Chaplin, et al.Journal of Medicinal Chemistry|April 28, 2012
Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas diseaseMartine Keenan, Michael J Abbott, Paul W Alexander, et al.Journal of Medicinal Chemistry|November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridinesDiego González Cabrera, Frederic Douelle, Yassir Younis, et al.Malaria Journal|January 4, 2020
An in vitro toolbox to accelerate anti-malarial drug discovery and developmentSusan A Charman, Alice Andreu, Helena Barker, et al.Journal of Medicinal Chemistry|December 6, 2013
Two analogues of fenarimol show curative activity in an experimental model of Chagas diseaseMartine Keenan, Jason H Chaplin, Paul W Alexander, et al.Journal of Medicinal Chemistry|January 5, 2017
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)Yuxiang Dong, Xiaofang Wang, Sriraghavan Kamaraj, et al.Bioorganic & Medicinal Chemistry|May 22, 2018
Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malariaPaul M O' Neill, Paul A Stocks, Sunil Sabbani, et al.Journal of Medicinal Chemistry|April 12, 2014
Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethersAaron Nilsen, Galen P Miley, Isaac P Forquer, et al.Journal of Medicinal Chemistry|August 23, 2016
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum TrypanosomacidesStephanie Russell, Raphaël Rahmani, Amy J Jones, et al.Pageof 5